OptimizeRx (NASDAQ:OPRX) vs. Triple P (OTCMKTS:TPPPF) Head to Head Contrast

OptimizeRx (NASDAQ:OPRX) and Triple P (OTCMKTS:TPPPF) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Analyst Ratings

This is a summary of current ratings and target prices for OptimizeRx and Triple P, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1	2	6	0	2.56
Triple P	0	0	0	0	0.00

OptimizeRx currently has a consensus price target of $13.43, indicating a potential upside of 157.99%. Given OptimizeRx’s stronger consensus rating and higher possible upside, equities analysts clearly believe OptimizeRx is more favorable than Triple P.

Institutional & Insider Ownership

76.5% of OptimizeRx shares are held by institutional investors. 5.6% of OptimizeRx shares are held by insiders. Comparatively, 39.0% of Triple P shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

OptimizeRx has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Comparatively, Triple P has a beta of 0.25, suggesting that its share price is 75% less volatile than the S&P 500.

Profitability

This table compares OptimizeRx and Triple P’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OptimizeRx	6.37%	10.86%	7.93%
Triple P	N/A	N/A	N/A

Earnings and Valuation

This table compares OptimizeRx and Triple P”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43 million	0.89	$5.13 million	$0.35	14.87
Triple P	N/A	N/A	N/A	N/A	N/A

OptimizeRx has higher revenue and earnings than Triple P.

Summary

OptimizeRx beats Triple P on 9 of the 10 factors compared between the two stocks.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About Triple P

Triple P. N.V. provides information and communication technology (ICT) infrastructure solutions. Its services include ICT security, cloud, managed services, managed IP telephony, professional services, business continuity, unified communications, and cloud migration. The company serves care, education, government, and commercial services sectors. Triple P. N.V. was founded in 1989 and is headquartered in Nieuwegein, the Netherlands.